Eurofins Scientific Future Growth
Future criteria checks 4/6
Eurofins Scientific is forecast to grow earnings and revenue by 20.4% and 7.4% per annum respectively. EPS is expected to grow by 19.9% per annum. Return on equity is forecast to be 12.3% in 3 years.
Key information
20.4%
Earnings growth rate
19.9%
EPS growth rate
Life Sciences earnings growth | 21.7% |
Revenue growth rate | 7.4% |
Future return on equity | 12.3% |
Analyst coverage | Good |
Last updated | 26 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 8,157 | 615 | 802 | 1,562 | 11 |
12/31/2025 | 7,596 | 557 | 723 | 1,372 | 13 |
12/31/2024 | 7,056 | 397 | 561 | 1,192 | 14 |
12/31/2023 | 6,515 | 257 | 468 | 1,018 | N/A |
9/30/2023 | 6,512 | 335 | 403 | 995 | N/A |
6/30/2023 | 6,510 | 414 | 339 | 971 | N/A |
3/31/2023 | 6,611 | 497 | 407 | 1,054 | N/A |
12/31/2022 | 6,712 | 581 | 476 | 1,136 | N/A |
9/30/2022 | 6,785 | 612 | 602 | 1,219 | N/A |
6/30/2022 | 6,857 | 643 | 727 | 1,301 | N/A |
3/31/2022 | 6,787 | 696 | 866 | 1,406 | N/A |
12/31/2021 | 6,718 | 749 | 1,005 | 1,511 | N/A |
9/30/2021 | 6,553 | 786 | 1,023 | 1,499 | N/A |
6/30/2021 | 6,388 | 824 | 1,041 | 1,487 | N/A |
3/31/2021 | 5,913 | 665 | 955 | 1,355 | N/A |
12/31/2020 | 5,439 | 505 | 868 | 1,224 | N/A |
9/30/2020 | 5,079 | 347 | 713 | 1,057 | N/A |
6/30/2020 | 4,719 | 190 | 558 | 891 | N/A |
3/31/2020 | 4,641 | 168 | 457 | 784 | N/A |
12/31/2019 | 4,563 | 146 | 355 | 678 | N/A |
9/30/2019 | 4,384 | 144 | 300 | 618 | N/A |
6/30/2019 | 4,205 | 143 | 244 | 558 | N/A |
3/31/2019 | 3,993 | 159 | 212 | 551 | N/A |
12/31/2018 | 3,781 | 175 | 180 | 544 | N/A |
9/30/2018 | 3,549 | 182 | 179 | 521 | N/A |
6/30/2018 | 3,318 | 190 | 178 | 498 | N/A |
3/31/2018 | 3,145 | 185 | 169 | 451 | N/A |
12/31/2017 | 2,971 | 179 | 159 | 405 | N/A |
9/30/2017 | 2,848 | 166 | N/A | 387 | N/A |
6/30/2017 | 2,725 | 152 | N/A | 369 | N/A |
3/31/2017 | 2,631 | 145 | N/A | 370 | N/A |
12/31/2016 | 2,537 | 138 | N/A | 372 | N/A |
9/30/2016 | 2,427 | 104 | N/A | 350 | N/A |
6/30/2016 | 2,317 | 69 | N/A | 328 | N/A |
3/31/2016 | 2,133 | 63 | N/A | 310 | N/A |
12/31/2015 | 1,950 | 56 | N/A | 291 | N/A |
9/30/2015 | 1,779 | 71 | N/A | 274 | N/A |
6/30/2015 | 1,609 | 86 | N/A | 256 | N/A |
3/31/2015 | 1,509 | 82 | N/A | 234 | N/A |
12/31/2014 | 1,410 | 78 | N/A | 212 | N/A |
9/30/2014 | 1,355 | 66 | N/A | 187 | N/A |
6/30/2014 | 1,299 | 53 | N/A | 162 | N/A |
3/31/2014 | 1,262 | 53 | N/A | 166 | N/A |
12/31/2013 | 1,226 | 53 | N/A | 169 | N/A |
9/30/2013 | 1,180 | 61 | N/A | 159 | N/A |
6/30/2013 | 1,134 | 69 | N/A | 148 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ESF's forecast earnings growth (20.4% per year) is above the savings rate (0.9%).
Earnings vs Market: ESF's earnings (20.4% per year) are forecast to grow faster than the Austrian market (2.7% per year).
High Growth Earnings: ESF's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: ESF's revenue (7.4% per year) is forecast to grow faster than the Austrian market (-2.8% per year).
High Growth Revenue: ESF's revenue (7.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ESF's Return on Equity is forecast to be low in 3 years time (12.3%).